1) Biological Warfare Defense Prophylaxis - Enabling Science
Abstract
This effort will focus on the development of alternate animal models and validation of microphysiological models that mimic the human system. Investment includes efforts to advance multiple models for prototype pathogens and chemical agents and validation of models to replace, reduce, or refine animal use in MCM development in alignment with Congressional requirements (the FDA Modernization Act 2.0). This capability will decrease the time and resources necessary to mount an effective medical response against biological and chemical threats.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2025
- Source ID
- 0082c8f1718d9f1a19fd077117f0234f